Incidence of Chronic Spontaneous Urticaria Following Receipt of the COVID-19 Vaccine Booster in Switzerland.
作者信息
Duperrex Olivier, Tommasini Francesco, Muller Yannick D
机构信息
Center for Primary Care and Public Health (Unisanté), Lausanne, Switzerland.
Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
出版信息
JAMA Netw Open. 2023 Feb 1;6(2):e2254298. doi: 10.1001/jamanetworkopen.2022.54298.
Abstract
摘要
相似文献
1
Incidence of Chronic Spontaneous Urticaria Following Receipt of the COVID-19 Vaccine Booster in Switzerland.瑞士接种新冠病毒疫苗加强针后慢性自发性荨麻疹的发病率
JAMA Netw Open. 2023 Feb 1;6(2):e2254298. doi: 10.1001/jamanetworkopen.2022.54298.
2
Chronic spontaneous urticaria following vaccination against SARS-CoV-2.接种新型冠状病毒疫苗后出现的慢性自发性荨麻疹。
Therapie. 2023 Nov-Dec;78(6):757-759. doi: 10.1016/j.therap.2022.12.007. Epub 2022 Dec 10.
3
Incidence and clinical course of COVID-19 in patients using omalizumab for chronic spontaneous urticaria and/or severe allergic asthma and using mepolizumab for severe eosinophilic asthma: A single center real life experience.奥马珠单抗治疗慢性自发性荨麻疹和/或严重过敏性哮喘和美泊利珠单抗治疗严重嗜酸性粒细胞性哮喘患者中 COVID-19 的发病和临床过程：一项单中心真实经验。
Tuberk Toraks. 2022 Sep;70(3):231-241. doi: 10.5578/tt.20229702.
4
Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink.基于树的数据分析在疫苗安全数据链中用于评估第一剂 COVID-19 加强针的安全性。
Vaccine. 2023 Jan 9;41(2):460-466. doi: 10.1016/j.vaccine.2022.11.053. Epub 2022 Nov 24.
5
Can mRNA COVID-19 vaccines induce flares of chronic urticaria?新型冠状病毒mRNA疫苗会引发慢性荨麻疹发作吗？
J Cosmet Dermatol. 2023 Jan;22(1):34-35. doi: 10.1111/jocd.15443. Epub 2022 Oct 25.
6
Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection: an observational study from routine surveillance data in Switzerland.评估 SARS-CoV-2 感染严重形式的真实世界疫苗有效性：来自瑞士常规监测数据的观察性研究。
Swiss Med Wkly. 2022 Apr 19;152:w30163. doi: 10.4414/smw.2022.w30163. eCollection 2022 Apr 11.
7
Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort Study.接受奥马珠单抗治疗的慢性特发性荨麻疹和哮喘患者中新型冠状病毒肺炎的发病率：一项多中心回顾性队列研究
J Cutan Med Surg. 2022 May-Jun;26(3):319-320. doi: 10.1177/12034754211049707. Epub 2021 Sep 29.
8
Urticaria relapse after mRNA COVID-19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single-center experience.抗组胺药联合奥马珠单抗治疗慢性自发性荨麻疹患者接种 mRNA COVID-19 疫苗后荨麻疹复发：单中心经验。
Dermatol Ther. 2022 Nov;35(11):e15838. doi: 10.1111/dth.15838. Epub 2022 Sep 27.
9
Safety of COVID-19 mRNA vaccination in children with chronic urticaria.新型冠状病毒肺炎信使核糖核酸疫苗在慢性荨麻疹儿童中的安全性。
J Allergy Clin Immunol Pract. 2023 Apr;11(4):1310-1313.e2. doi: 10.1016/j.jaip.2022.12.029. Epub 2023 Jan 5.
10
Retrospective evaluation of patients with chronic spontaneous urticaria using omalizumab during the COVID-19 pandemic.在新冠疫情期间使用奥马珠单抗对慢性自发性荨麻疹患者进行回顾性评估。
J Cosmet Dermatol. 2022 Feb;21(2):431-434. doi: 10.1111/jocd.14725. Epub 2022 Jan 4.
引用本文的文献
1
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).在一项1期随机开放标签临床试验（HVTN 302）中，研究性HIV-1 BG505 MD39.3三聚体mRNA疫苗接种后慢性荨麻疹的高发生率
Ann Intern Med. 2025 Jul;178(7):963-974. doi: 10.7326/ANNALS-24-02701. Epub 2025 Apr 29.
2
Global Burden of Vaccine-Associated Chronic Urticaria, 2010-2023: From the Global Pharmacovigilance Database.2010 - 2023年疫苗相关慢性荨麻疹的全球负担：来自全球药物警戒数据库
Allergy Asthma Immunol Res. 2024 Nov;16(6):613-625. doi: 10.4168/aair.2024.16.6.613.
3
Features of chronic urticaria after COVID-19 mRNA vaccine over time.新冠mRNA疫苗接种后慢性荨麻疹随时间变化的特征
Commun Med (Lond). 2024 Nov 30;4(1):254. doi: 10.1038/s43856-024-00656-y.
4
Clinical presentation, associated factors, and course of cutaneous reaction after the booster dose of COVID-19 vaccination.新冠疫苗加强针接种后皮肤反应的临床表现、相关因素及病程
Clin Exp Vaccine Res. 2024 Oct;13(4):309-314. doi: 10.7774/cevr.2024.13.4.309. Epub 2024 Oct 31.
5
A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria.诊断和管理慢性自发性荨麻疹的实用方法
Dermatol Ther (Heidelb). 2024 Jun;14(6):1371-1387. doi: 10.1007/s13555-024-01173-5. Epub 2024 May 17.
6
How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19.感染和疫苗接种与急性和慢性荨麻疹的关系：特别关注 COVID-19。
Viruses. 2023 Jul 20;15(7):1585. doi: 10.3390/v15071585.
7
Error in Table 1 and Results.表1及结果中的错误。
JAMA Netw Open. 2023 Apr 3;6(4):e239463. doi: 10.1001/jamanetworkopen.2023.9463.
本文引用的文献
1
Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance.新冠病毒 mRNA 疫苗皮内试验可预测耐受性。
Front Allergy. 2022 May 31;3:818049. doi: 10.3389/falgy.2022.818049. eCollection 2022.
2
Clinical and immunological data from chronic urticaria onset after mRNA SARS-CoV-2 vaccines.新冠病毒mRNA疫苗接种后慢性荨麻疹发病的临床和免疫学数据。
Clin Exp Allergy. 2022 Nov;52(11):1343-1346. doi: 10.1111/cea.14214. Epub 2022 Aug 23.
3
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients.免疫功能低下患者的 COVID-19 mRNA 疫苗针对关注变种的体液反应。
JAMA Oncol. 2022 May 1;8(5):e220446. doi: 10.1001/jamaoncol.2022.0446. Epub 2022 May 19.
4
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.国际 EAACI/GA²LEN/EuroGuiDerm/APAAACI 荨麻疹定义、分类、诊断和管理指南。
Allergy. 2022 Mar;77(3):734-766. doi: 10.1111/all.15090. Epub 2021 Oct 20.
Zotero 插件